Pirfenidone MR vs IR PK Study in Healthy Chinese Subjects

Phase 1, randomised, open-label trial of pirfenidone in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Overseas Pharmaceuticals. Primary endpoints: Area under the curve from time zero to the time of the last quantifiable plasma concentration and Area under the curve from time zero to infinity. Started Aug 2023; status: completed.